Rosemary Petric

2.4k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Rosemary Petric is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Rosemary Petric has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in Rosemary Petric's work include Pharmacological Effects and Toxicity Studies (5 papers), Asthma and respiratory diseases (5 papers) and Mast cells and histamine (4 papers). Rosemary Petric is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), Asthma and respiratory diseases (5 papers) and Mast cells and histamine (4 papers). Rosemary Petric collaborates with scholars based in Canada, United States and Singapore. Rosemary Petric's co-authors include Martin L. Hibberd, Denis Bertrand, Niranjan Nagarajan, Grace Hui Ting Yeo, Chiea Chuen Khor, Pauline Aw, Swee Hoe Ong, Andreas Wilm, Anthony W. Ford‐Hutchinson and Paul Keown and has published in prestigious journals such as Nucleic Acids Research, Kidney International and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Rosemary Petric

18 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

2012 840 citations Andreas Wilm, Pauline Aw et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosemary Petric Canada	13	432	271	251	192	172	18	1.3k
Heather L. Stevenson United States	21	280 0.6×	340 1.3×	314 1.3×	218 1.1×	99 0.6×	100	1.4k
Eric J. Jacobs United States	13	565 1.3×	314 1.2×	288 1.1×	177 0.9×	214 1.2×	16	1.6k
Patcharin Pramoonjago United States	23	458 1.1×	264 1.0×	526 2.1×	492 2.6×	167 1.0×	45	1.7k
Takahito Sanada Japan	16	703 1.6×	204 0.8×	220 0.9×	547 2.8×	134 0.8×	25	1.5k
B. Giesendorf Netherlands	19	620 1.4×	244 0.9×	134 0.5×	138 0.7×	113 0.7×	23	1.6k
Vicki E. Smith United Kingdom	24	414 1.0×	534 2.0×	147 0.6×	123 0.6×	171 1.0×	46	1.7k
Craig M. Bielski United States	8	1.3k 3.1×	390 1.4×	223 0.9×	184 1.0×	295 1.7×	11	2.0k
Shou‐Hwa Han Taiwan	20	453 1.0×	119 0.4×	426 1.7×	271 1.4×	77 0.4×	52	1.3k
Linbai Ye China	18	327 0.8×	450 1.7×	342 1.4×	213 1.1×	112 0.7×	36	1.2k

Countries citing papers authored by Rosemary Petric

Since Specialization

Citations

This map shows the geographic impact of Rosemary Petric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Petric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Petric more than expected).

Fields of papers citing papers by Rosemary Petric

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Petric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Petric. The network helps show where Rosemary Petric may publish in the future.

Co-authorship network of co-authors of Rosemary Petric

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Petric. A scholar is included among the top collaborators of Rosemary Petric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Petric. Rosemary Petric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Okubo, Yukari, Mamitaro Ohtsuki, Mayumi Komine, et al.. (2021). Population pharmacokinetic and exposure–response analysis of apremilast in Japanese subjects with moderate to severe psoriasis. The Journal of Dermatology. 48(11). 1652–1664. 3 indexed citations

Imafuku, Shinichi, Osamu Nemoto, Yukari Okubo, et al.. (2020). Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial. The Journal of Dermatology. 48(1). 80–84. 8 indexed citations

Reich, Kristian, Melinda Gooderham, Anthony Bewley, et al.. (2017). Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study. Journal of the European Academy of Dermatology and Venereology. 32(3). 397–402. 50 indexed citations

Ohtsuki, Mamitaro, Yukari Okubo, Mayumi Komine, et al.. (2017). Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial. The Journal of Dermatology. 44(8). 873–884. 57 indexed citations

Tan, Anthony T., Long Hoàng, Daniel J. Chin, et al.. (2013). Reduction of HBV replication prolongs the early immunological response to IFNα therapy. Journal of Hepatology. 60(1). 54–61. 62 indexed citations

Niet, A. de, Louis Jansen, Hans L. Zaaijer, et al.. (2013). Experimental Hbsag/Anti-Hbs Complex Assay for Prediction of Hbeag Loss in Chronic Hepatitis B Patients Treated with Pegylated Interferon and Adefovir. Antiviral Therapy. 19(3). 259–267. 10 indexed citations

Gane, Edward, Roman Rouzier, Alicja Wiercińska‐Drapało, et al.. (2013). Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a–Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders. Antimicrobial Agents and Chemotherapy. 58(2). 1136–1145. 15 indexed citations

Simmons, Cameron P., Marcel Wolbers, Nguyet Minh Nguyen, et al.. (2012). Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials. PLoS neglected tropical diseases. 6(9). e1752–e1752. 21 indexed citations

Wilm, Andreas, Pauline Aw, Denis Bertrand, et al.. (2012). LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Research. 40(22). 11189–11201. 840 indexed citations breakdown →

10.

Flinn, Ian W., John C. Byrd, Nancy L. Bartlett, et al.. (2005). Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity. Leukemia Research. 29(11). 1253–1257. 78 indexed citations

11.

Petric, Rosemary & Anthony W. Ford‐Hutchinson. (1995). Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritis. PubMed. 11(3). 231–240. 13 indexed citations

12.

Petric, Rosemary, Donald W. Nicholson, & Anthony W. Ford‐Hutchinson. (1995). Renal leukotriene C4 synthase: characterization, partial purification and alterations in experimental glomerulonephritis. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1254(2). 207–215. 11 indexed citations

13.

Petric, Rosemary & Anthony W. Ford‐Hutchinson. (1994). Elevated cysteinyl leukotriene excretion in experimental glomerulonephritis. Kidney International. 46(5). 1322–1329. 18 indexed citations

14.

Petric, Rosemary, et al.. (1992). Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition.. PubMed. 54(6). 1103–6. 5 indexed citations

15.

Petric, Rosemary, et al.. (1990). MODULATION OF EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY BY INHIBITION OF THROMBOXANE SYNTHESIS. Transplantation. 50(4). 558–563. 19 indexed citations

16.

Petric, Rosemary, et al.. (1988). EFFECT OF CYCLOSPORINE ON URINARY PROSTANOID EXCRETION, RENAL BLOOD FLOW, AND GLOMERULOTUBULAR FUNCTION. Transplantation. 45(5). 883–889. 40 indexed citations

17.

Jevnikar, Anthony M., et al.. (1988). EFFECT OF CYCLOSPORINE ON PLASMA LIPIDS AND MODIFICATION WITH DIETARY FISH OIL. Transplantation. 46(5). 722–725. 38 indexed citations

18.

Ryffel, Bernhard, et al.. (1986). Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions.. PubMed. 25 Suppl 1. S193–8. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact